In re Abilify (Aripiprazole) Products Liability Litigation
United States District Court for the Northern District of Florida
2017 WL 6757558, No. 3:16-MDL-2734 (2017)
- Written by Brianna Pine, JD
Facts
Individuals who took the prescription drug Abilify (consumers) (plaintiffs) brought suit against Bristol-Myers Squibb Company and Otsuka America Pharmaceutical Inc. (companies) (defendants). The consumers filed a motion to compel the production of certain documents listed on the companies’ privilege logs. The consumers raised three challenges to the companies’ withholding of the documents: first, that the descriptions contained in the privilege logs were inadequate; second, that documents withheld on the basis of work-product protection did not qualify as work product; and third, that documents withheld on the basis of attorney-client privilege were not privileged. The companies filed an opposition to the motion and submitted all the documents on their privilege logs for in camera review.
Rule of Law
Issue
Holding and Reasoning (Jones, J.)
What to do next…
Here's why 899,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 47,000 briefs, keyed to 994 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.
